BiltRx Compounded Tirzepatide
Licensed telehealth provider offering compounded tirzepatide at a flat $129 per month through US 503A pharmacies. Brand-name Mounjaro and Zepbound also available at $1,499.
Find the cheapest tirzepatide in 2026. We rank compounded providers, self-pay vials and savings cards by total monthly cost with source links for every price.
Licensed telehealth provider offering compounded tirzepatide at a flat $129 per month through US 503A pharmacies. Brand-name Mounjaro and Zepbound also available at $1,499.
We look for a batch-level certificate of analysis published by the merchant.
Purity percentage and milligrams per vial as stated on the product page.
Clear research-use labeling, lot numbers and storage instructions.
Vials compared on price per milligram, not on sticker price.
Licensed telehealth provider offering compounded tirzepatide at a flat $129 per month through US 503A pharmacies. Brand-name Mounjaro and Zepbound also available at $1,499.

Dose-tiered compounded tirzepatide with glycine and B12 from $199.99 per month. Free consultation and free expedited shipping included in all plans.
| Product | Monthly | Form | Rx | Pharmacy | Price |
|---|---|---|---|---|---|
| BiltRx BiltRx Compounded Tirzepatide | $129 | Injectable | Required | US 503A | $129/mo |
| Arc-1 Arc-1 Compounded Tirzepatide + Glycine + B | - | Injectable | - | - | From $199.99 |
To locate the lowest-priced version of tirzepatide, one needs to navigate through various manufacturers’ programs, compounded options and insurance alternatives. We have ranked all possible legal options according to the actual monthly out-of-pocket price, confirming all rates in October 2026. The table below shows prices starting at $25 and going up.
| Rank | Option | Monthly Cost | Who Qualifies | Source / Verified |
|---|---|---|---|---|
| 1 | Savings card + commercial insurance | As low as $25 | Commercially insured patients | zepbound.lilly.com, Oct 2026 |
| 2 | Medicare GLP-1 Bridge | $50 | Medicare Part D enrollees | LillyDirect, Oct 2026 |
| 3 | BiltRx compounded | $129 | Anyone with Rx (consult + shipping extra) | biltrx.com, verified 22 Oct 2026 |
| 4 | Arc-1 compounded (2.5 mg) | $199.99 | Rx required; not available in CA, AR, IN, MN, SC | arc-1.co, verified 22 Oct 2026 |
| 5 | Arc-1 compounded (5 mg) | $249.99 | Same restrictions as above | arc-1.co, verified 22 Oct 2026 |
| 6 | Zepbound self-pay vial (2.5 mg, 45-day refill) | $299 | Uninsured or uncovered patients | LillyDirect, Oct 2026 |
| 7 | Zepbound self-pay vial (5 mg, 45-day refill) | $399 | Same | LillyDirect, Oct 2026 |
| 8 | Arc-1 compounded (7.5 mg) | $399.99 | Same state restrictions | arc-1.co, verified 22 Oct 2026 |
| 9 | Zepbound self-pay vial (7.5-15 mg, 45-day refill) | $449 | Uninsured or uncovered | LillyDirect, Oct 2026 |
| 10 | Mounjaro self-pay (all doses) | $499 | Uninsured or uncovered | LillyDirect, Oct 2026 |
| 11 | Zepbound self-pay (7.5 mg, no refill window) | $499 | Same | LillyDirect, Oct 2026 |
| 12 | Zepbound self-pay (10-15 mg, no refill window) | $699 | Same | LillyDirect, Oct 2026 |
| 13 | Retail pharmacy cash (Mounjaro) | $1,000 - $1,085 | Anyone with Rx | Retail estimates, Oct 2026 |
| 14 | Retail pharmacy cash (Zepbound) | $1,000 - $1,135 | Anyone with Rx | Retail estimates, Oct 2026 |
| 15 | Wegovy (for reference) | $1,349 | Semaglutide, not tirzepatide | NovoCare, Oct 2026 |
The machines put the product cards for BiltRx and Arc-1 on this page. For both medications, a prescription is required from the licenced creator. Each of the cards contains a current price, editorial rating, and direct link to it. For details about both drugs, click here BiltRx vs Arc-1 comparison.
503A pharmacies use the unbranded component of tirzepatide with no clinical testing, advertising, or device expenses incurred by Lilly. BiltRx has a fixed rate of $129/month regardless of the amount used (biltrx.com, checked on 22 Oct 2026). Arc-1 charges vary based on the dose: $199.99 for 2.5 mg, $249.99 for 5 mg, and $399.99 for 7.5 mg, shipping and consultation included (arc-1.co, checked on 22 Oct 2026).
The compromise: compounded tirzepatide does not have approval from FDA as finished product. BiltRx is filling through 503A pharmacies. Arc-1 is certified by LegitScript and the formulation includes glycine and vitamin B12. Neither of the products has FDA approval comparable to Mounjaro or Zepbound. Our compounded vs brand page discusses quality issues in more details.
Those patients looking for an FDA-endorsed product while spending the least amount of money possible might consider the LillyDirect single-dose vial initiative by Lilly.
Zepbound vials are available through LillyDirect only. October 2026 pricing: $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 through 15 mg with the 45-day refill window. Without it: $499 at 7.5 mg and $699 at 10 through 15 mg. These are vials, not KwikPen devices. You draw the dose with a syringe. The vials contain the same FDA-approved tirzepatide. This undercuts retail cash by $600 or more per month. Pharmacy-by-pharmacy pricing is on our Zepbound cost without insurance page.
The lower tier ($299/$399/$449) needs to be refilled within 45 days. If you forget to refill, the cost of that refill will be $499 at 7.5 mg or $699 at 10 through 15 mg. You can return to the lower tier again at your next order if you meet this deadline. However, the prices for both 2.5 mg and 5 mg remain unchanged, hence this only affects those patients taking greater than 7.5 mg.
Insurance-linked programs present the lowest prices, however, this applies only to individuals whose insurance plan covers that medication.
Commercially insured individuals can use the Lilly savings card to get their copay reduced to as low as $25 a month (zepbound.lilly.com, October 2026). There are annual limits allowed and the use of this card is not available for Medicare, Medicaid, TRICARE, and other government plans. Activate card at the Lilly website and take to the pharmacy. More detailed guidelines can be found on our savings card guide.
Those who enroll in Medicare Part D are eligible for the GLP-1 Bridge for $50 per month in LillyDirect. There is a flat pricing scheme for all dosage levels. To enroll in the program, you must have enrolled in Part D and have a valid prescription. This program is sponsored by Lilly, so it is not a Part D benefit. Check our monthly cost guide for the 12-month projection.
There are different tirzepatide suppliers on the internet that are more affordable than the suppliers mentioned above. However, low cost alone is not the basis for deeming a supplier reputable. There are two categories where we feel the risks from a legal and safety standpoint make them undesirable, regardless of the cost savings.
Certain websites offer "tirzepatide" under the title "for research use only." These products are not classified as prescription medications and do not come under FDA or state pharmacy board surveillance. Purity level, sterility as well as peptide contents are unverifiable. The FDA has issued specific warnings about unapproved tirzepatide products. There is no possible way to justify the use of an unregulated compound in a medical practice just based on the cost.
According to federal law, overseas pharmacies are not allowed to sell tirzepatide in the United States without a valid US prescription. It is important to remember that shipping of medications that need refrigeration can be unreliable and even packages that have been stuck in customs can lose their effectiveness completely. Problems can arise with fake GLP-1 medications that can be stopped by US authorities before these drugs enter the US market.
BiltRx compounded tirzepatide at $129 per month is the lowest base price we verified as of October 2026 (biltrx.com). Consultation and shipping fees are additional. Among brand-name options, Zepbound self-pay vials through LillyDirect start at $299 per month at 2.5 mg with the 45-day refill window. Both options require a prescription. For a complete side-by-side of all pricing tiers, see our tirzepatide cost overview.
It uses the same active component as Mounjaro and Zepbound. Safety relies on sourcing, production and testing done by the pharmacy. Compounded formulations cannot be approved by the FDA, meaning that there is no assurance of quality at federal level. Opting for a licensed 503A pharmacy that is LegitScript certified minimizes the risk involved. Our compounded effectiveness page tells you everything there is to know.
Certainly, with your prescribing physician involved, this process is simple. The medication is the same active substance, and so the switch does not present any difficulties. However, the prepared formulation may differ with respect to the dose, method of administration, or additional components (for example, Arc-1 contains glycine and vitamin B12). Your doctor will have to adjust the prescription accordingly. No medical downtime is necessary to switch from brand-name tirzepatide to the compounded medication.
Check three details: an active pharmacy license from your state pharmacy board, 503A registration, and voluntary certifications like LegitScript or PCAB. A pharmacy that ships tirzepatide without requiring a prescription is not operating legally. Only those pharmacies listed in provider directory can guarantee adherence to all three points.

Prices, sizes and ratings side by side, updated when the merchant pages change.
See lowest prices